Updated On: 14 July, 2021 08:41 AM IST | New Delhi | Agencies
Pune-based vaccine manufacturer and Russian Direct Investment Fund say they intend to produce 30 crore doses of the vaccine in India in a year

A medic prepares a dose of Sputnik V to vaccinate a beneficiary, at a hospital in Kochi, on Tuesday. Pic/PTI
Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday. As per the agreement between RDIF and SII, the parties intend to produce over 30 crore doses of the vaccine in India per year. “The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF, Russia’s sovereign wealth fund, said in a statement.
As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Centre. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun, RDIF said.